BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Return 63.34%
This Quarter Return
-18.21%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$12.2B
AUM Growth
-$2.97B
Cap. Flow
-$42.5M
Cap. Flow %
-0.35%
Top 10 Hldgs %
86.1%
Holding
101
New
4
Increased
12
Reduced
21
Closed
10

Top Buys

1
ACAD icon
Acadia Pharmaceuticals
ACAD
$182M
2
AMRN
Amarin Corp
AMRN
$116M
3
KOD icon
Kodiak Sciences
KOD
$64.9M
4
CMTA
Clementia Pharmaceuticals Inc.
CMTA
$21.1M
5
KRYS icon
Krystal Biotech
KRYS
$13.9M

Top Sells

1
GHDX
Genomic Health, Inc.
GHDX
$132M
2
SAGE
Sage Therapeutics
SAGE
$80.2M
3
NVTA
Invitae Corporation
NVTA
$49.7M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
$45.3M
5
GLPG icon
Galapagos
GLPG
$19.5M

Sector Composition

1 Healthcare 92.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FSTX
51
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$6.37M 0.05%
153,286
– –
ALBO
52
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$6.13M 0.05%
250,000
– –
CPRX icon
53
Catalyst Pharmaceutical
CPRX
$2.4B
$5.57M 0.05%
2,900,000
– –
AUTL
54
Autolus Therapeutics
AUTL
$381M
$5.15M 0.04%
156,773
-78,521
-33% -$2.58M
HALO icon
55
Halozyme
HALO
$8.66B
$4.39M 0.04%
299,969
-150,000
-33% -$2.19M
BLUE
56
DELISTED
bluebird bio
BLUE
$3.97M 0.03%
3,088
-1,501
-33% -$1.93M
CRNX icon
57
Crinetics Pharmaceuticals
CRNX
$3.17B
$3.94M 0.03%
131,250
– –
FTSV
58
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$3.93M 0.03%
250,000
– –
XLRN
59
DELISTED
Acceleron Pharma Inc.
XLRN
$3.65M 0.03%
83,900
– –
ASMB icon
60
Assembly Biosciences
ASMB
$174M
$3.36M 0.03%
12,382
– –
VKTX icon
61
Viking Therapeutics
VKTX
$2.94B
$3.25M 0.03%
425,000
– –
SYRS
62
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.2M 0.03%
57,484
– –
VYNE icon
63
VYNE Therapeutics
VYNE
$7.86M
$2.88M 0.02%
9,722
– –
GNMX
64
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$2.77M 0.02%
3,950,419
– –
SRRA
65
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.64M 0.02%
+50,000
New +$2.64M
APLS icon
66
Apellis Pharmaceuticals
APLS
$3.5B
$2.59M 0.02%
196,078
– –
GTHX
67
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.44M 0.02%
127,236
– –
GLPG icon
68
Galapagos
GLPG
$2.05B
$2.3M 0.02%
25,072
-212,119
-89% -$19.5M
CCXI
69
DELISTED
ChemoCentryx, Inc.
CCXI
$2.26M 0.02%
207,029
-207,000
-50% -$2.26M
YMAB icon
70
Y-mAbs Therapeutics
YMAB
$389M
$2.09M 0.02%
102,800
-47,200
-31% -$960K
ALKS icon
71
Alkermes
ALKS
$4.78B
$1.98M 0.02%
67,000
-33,251
-33% -$981K
ORTX
72
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.97M 0.02%
+12,500
New +$1.97M
FOMX
73
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.79M 0.01%
498,189
-189,886
-28% -$682K
NTLA icon
74
Intellia Therapeutics
NTLA
$1.23B
$1.76M 0.01%
128,538
-64,000
-33% -$874K
ACHN
75
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$1.74M 0.01%
1,095,359
-544,589
-33% -$866K
1 2
3
4